In this recent publication, the authors report that high-risk HPV types 16,18, 31, 33, 45, and 52 were found to contribute substantially to low-grade cytological abnormalities. The data contributing to these analyses were collected over a period of 14-years of follow-up of a nationwide randomized HPV screening trial in Sweden. The results could be useful for the design and evaluation of HPV type-specific vaccines, screening tests and clinical management algorithms.
Elfstrom KM, Smelov V, Johansson AL et al. Long-term HPV type-specific risks for ASCUS and LSIL: a 14-year follow-up of a randomized primary HPV screening trial. Int J Cancer 2014, May 20. doi: 10.1002/ijc.28984